Management of COVID-19-Related Acute Respiratory Distress Syndrome (ARDS)

Initial Respiratory Support Strategies

• The European Respiratory Society recommends high-flow nasal cannula oxygen (HFNC) or noninvasive continuous positive airway pressure (CPAP) for initial management of hypoxemic respiratory failure in patients with COVID-19, with close monitoring for worsening respiratory status and early intubation in a controlled setting if deterioration occurs 1, 2
• Noninvasive strategies should be implemented in a safe environment with appropriate personal protective equipment as they are considered aerosol-generating procedures 1

Mechanical Ventilation Strategies for COVID-19 ARDS

• The European Society of Intensive Care Medicine recommends lung-protective ventilation strategies, including low tidal volume ventilation (4-8 mL/kg of predicted body weight), targeting plateau pressures <30 cm H₂O, and implementing a higher PEEP strategy (>10 cm H₂O) with monitoring for barotrauma in moderate to severe ARDS 2
• A conservative fluid strategy is recommended rather than liberal fluid management, and prone positioning for 12-16 hours in patients with moderate to severe ARDS 2
• Intermittent boluses of neuromuscular blocking agents (NMBA) may be considered to facilitate protective lung ventilation, with continuous NMBA infusion for up to 48 hours in cases of persistent ventilator dyssynchrony, need for deep sedation, prone ventilation, or persistently high plateau pressures 2

Adjunctive Therapies

• Systemic corticosteroids are recommended for mechanically ventilated patients with COVID-19 ARDS, with low-dose, short-course methylprednisolone (30-80 mg/day for 3-5 days) having been used, although clear evidence of improved outcomes is lacking 2, 3, 4, 5
• Prone positioning for 12-16 hours is recommended for mechanically ventilated patients with moderate to severe ARDS, and may also be beneficial in non-intubated patients 1, 2

Antimicrobial Therapy

• Empiric antimicrobial/antibacterial agents are suggested for mechanically ventilated COVID-19 patients with respiratory failure, with daily assessment for de-escalation and monitoring for bacterial superinfection with standard microbiological testing 2, 6

Monitoring Recommendations

• Vital signs, including heart rate, pulse oxygen saturation, respiratory rate, and blood pressure, should be monitored, along with laboratory parameters such as blood routine, CRP, PCT, organ function, coagulation function, and arterial blood gas analysis 3, 5
• Regular chest imaging and point-of-care ultrasound can be useful to assess disease progression and minimize patient transfers 3, 5